Improving Outcomes with First-Line Endocrine-Based Therapy for Patients with HR-Positive, HER2-Negative Metastatic Breast Cancer - Oncology Today with Dr Neil Love

Artwork for podcast Oncology Today with Dr Neil Love

Improving Outcomes with First-Line Endocrine-Based Therapy for Patients with HR-Positive, HER2-Negative Metastatic Breast Cancer

1st November 2024 • Oncology Today with Dr Neil Love • Research To Practice